Investigational Chemotherapy Service

Durham, North Carolina 27710

We've found

3 trials

at this facility

A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Durham, NC

Phase 1 Study Of PF-06863135, A BCMA- CD3 Bispecific Ab, In Relapse/ Refractory Multiple Myeloma

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Durham, NC

Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Durham, NC

Use our guide to learn which trials are right for you!